9种获批上市的抗PD-1/PD-L1单抗药物的特征综述(4)
[ 5 ] HERBST RS，BAAS P，KIM DW，et al. Pembrolizumab versus docetaxel for previously treated，PD-L1-positive，advanced non-small-cell lung cancer(KEYNOTE-010)：a randomised controlled trial[J]. Lancet，2016，387(10027)：1540-1550.[ 6 ] RITTMEYER A，BARLESI F，WATERKAMP D，et al. Atezolizumab versus docetaxel in patients with previously treated non-small-cell lung cancer(OAK)：a phase 3 ......
您现在查看是摘要页，全文长 2679 字符。